Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated:  3/5/2018
DFW Center for Spinal Disorders
mi
from
Fort Worth, TX
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated: 3/5/2018
DFW Center for Spinal Disorders
mi
from
Fort Worth, TX
Click here to add this to my saved trials
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated:  3/5/2018
Tallahassee Neurological Clinic
mi
from
Tallahassee, FL
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated: 3/5/2018
Tallahassee Neurological Clinic
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Comparison of the Aspen Device Versus Pedicle Screws for Supplemental Posterior Fixation in Lumbar Interbody Fusion
A Multi-Center Prospective Randomized Study Comparing Supplemental Posterior Instrumentation, Aspen™ Spinous Process System Versus Pedicle Screw Fixation, in Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF)
Status: Enrolling
Updated:  3/5/2018
Clint Hill
mi
from
Paducah, KY
Comparison of the Aspen Device Versus Pedicle Screws for Supplemental Posterior Fixation in Lumbar Interbody Fusion
A Multi-Center Prospective Randomized Study Comparing Supplemental Posterior Instrumentation, Aspen™ Spinous Process System Versus Pedicle Screw Fixation, in Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF)
Status: Enrolling
Updated: 3/5/2018
Clint Hill
mi
from
Paducah, KY
Click here to add this to my saved trials
Comparison of the Aspen Device Versus Pedicle Screws for Supplemental Posterior Fixation in Lumbar Interbody Fusion
A Multi-Center Prospective Randomized Study Comparing Supplemental Posterior Instrumentation, Aspen™ Spinous Process System Versus Pedicle Screw Fixation, in Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF)
Status: Enrolling
Updated:  3/5/2018
Buffalo Spine Surgery
mi
from
Lockport, NY
Comparison of the Aspen Device Versus Pedicle Screws for Supplemental Posterior Fixation in Lumbar Interbody Fusion
A Multi-Center Prospective Randomized Study Comparing Supplemental Posterior Instrumentation, Aspen™ Spinous Process System Versus Pedicle Screw Fixation, in Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF)
Status: Enrolling
Updated: 3/5/2018
Buffalo Spine Surgery
mi
from
Lockport, NY
Click here to add this to my saved trials
Comparison of the Aspen Device Versus Pedicle Screws for Supplemental Posterior Fixation in Lumbar Interbody Fusion
A Multi-Center Prospective Randomized Study Comparing Supplemental Posterior Instrumentation, Aspen™ Spinous Process System Versus Pedicle Screw Fixation, in Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF)
Status: Enrolling
Updated:  3/5/2018
Andy Kranenburg
mi
from
Medford, OR
Comparison of the Aspen Device Versus Pedicle Screws for Supplemental Posterior Fixation in Lumbar Interbody Fusion
A Multi-Center Prospective Randomized Study Comparing Supplemental Posterior Instrumentation, Aspen™ Spinous Process System Versus Pedicle Screw Fixation, in Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF)
Status: Enrolling
Updated: 3/5/2018
Andy Kranenburg
mi
from
Medford, OR
Click here to add this to my saved trials
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
Status: Enrolling
Updated:  3/5/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
Status: Enrolling
Updated: 3/5/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study Comparing 3 Different Treatments for Arthritis of the Lower Back (Lumbar Spinal Stenosis)
A Comparison of Non-Surgical Treatment Methods for Patients With Lumbar Spinal Stenosis
Status: Enrolling
Updated:  3/5/2018
UPMC Shadyside Center for Integrative Medicine
mi
from
Pittsburgh, PA
Study Comparing 3 Different Treatments for Arthritis of the Lower Back (Lumbar Spinal Stenosis)
A Comparison of Non-Surgical Treatment Methods for Patients With Lumbar Spinal Stenosis
Status: Enrolling
Updated: 3/5/2018
UPMC Shadyside Center for Integrative Medicine
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Osteogenesis Imperfecta (OI) Quality of Life Survey Pilot Project 2
Rare Diseases Clinical Research Network Brittle Bone Disorders Consortium Osteogenesis Imperfecta (OI) Quality of Life Survey Pilot Project 2
Status: Enrolling
Updated:  3/5/2018
University of South Florida, Health Informatics Institute
mi
from
Tampa, FL
Osteogenesis Imperfecta (OI) Quality of Life Survey Pilot Project 2
Rare Diseases Clinical Research Network Brittle Bone Disorders Consortium Osteogenesis Imperfecta (OI) Quality of Life Survey Pilot Project 2
Status: Enrolling
Updated: 3/5/2018
University of South Florida, Health Informatics Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Improving Gait Performance in Individuals With Spinal Cord Injuries: an Intervention Using Robotic Exoskeletons
Improving Gait Performance in Individuals With Spinal Cord Injuries: an Intervention Using Robotic Exoskeletons
Status: Enrolling
Updated:  3/5/2018
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Improving Gait Performance in Individuals With Spinal Cord Injuries: an Intervention Using Robotic Exoskeletons
Improving Gait Performance in Individuals With Spinal Cord Injuries: an Intervention Using Robotic Exoskeletons
Status: Enrolling
Updated: 3/5/2018
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Pain Management in Children Undergoing Supracondylar Humerus Fracture Repair
Pain Management in Children Undergoing Supracondylar Humerus Fracture Repair: Can a Local Supraclavicular Block Improve Their Postoperative Outcome?
Status: Enrolling
Updated:  3/6/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Pain Management in Children Undergoing Supracondylar Humerus Fracture Repair
Pain Management in Children Undergoing Supracondylar Humerus Fracture Repair: Can a Local Supraclavicular Block Improve Their Postoperative Outcome?
Status: Enrolling
Updated: 3/6/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Southwestern American Indian Center
mi
from
Phoenix, AZ
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Southwestern American Indian Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Southern California
mi
from
Los Angeles, CA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Louisiana State University
mi
from
Baton Rouge, LA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Louisiana State University
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Johns Hopkins Pro-Health
mi
from
Baltimore, MD
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Johns Hopkins Pro-Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Diabetes Center
mi
from
Boston, MA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Joslin Diabetes Center
mi
from
Boston, MA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Northern Navajo Medical Center
mi
from
Shiprock, NM
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Northern Navajo Medical Center
mi
from
Shiprock, NM
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Columbia University
mi
from
New York, NY
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
The University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
The University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Miriam Hospital
mi
from
Providence, RI
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Tennessee, Memphis
mi
from
Memphis, TN
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Tennessee, Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Baylor College of Medicine
mi
from
Houston, TX
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Univ of Washington
mi
from
Seattle, WA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated:  3/8/2018
Clinical Research Facility
mi
from
Los Angeles, CA
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/8/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated:  3/8/2018
Clinical Research Facility
mi
from
Chapel Hill, NC
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/8/2018
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated:  3/8/2018
Clinical Research Facility
mi
from
Durham, NC
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/8/2018
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated:  3/8/2018
mi
from
Maastricht,
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/8/2018
mi
from
Maastricht,
Click here to add this to my saved trials
Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks
Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks
Status: Enrolling
Updated:  3/8/2018
University of California, San Diego
mi
from
San Diego, CA
Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks
Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks
Status: Enrolling
Updated: 3/8/2018
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Obstructive Sleep Apnea in Elective Orthopaedic Surgery
Effects of Obstructive Sleep Apnea in Elective Orthopaedic Surgery
Status: Enrolling
Updated:  3/8/2018
University of Miami Hospital
mi
from
Miami, FL
Obstructive Sleep Apnea in Elective Orthopaedic Surgery
Effects of Obstructive Sleep Apnea in Elective Orthopaedic Surgery
Status: Enrolling
Updated: 3/8/2018
University of Miami Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors
Phase 2 Study Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors
Status: Enrolling
Updated:  3/9/2018
Park Nicollet Frauenshuh Cancer Center
mi
from
Minneapolis, MN
Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors
Phase 2 Study Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors
Status: Enrolling
Updated: 3/9/2018
Park Nicollet Frauenshuh Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain
A Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain: A Randomized Control Trial
Status: Enrolling
Updated:  3/9/2018
Northern Arizona University
mi
from
Flagstaff, AZ
A Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain
A Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain: A Randomized Control Trial
Status: Enrolling
Updated: 3/9/2018
Northern Arizona University
mi
from
Flagstaff, AZ
Click here to add this to my saved trials
Benefit of Adding Stretching to Standard Intervention For Patients With Nonspecific Mechanical Neck Pain
Benefit of Adding Stretching to Standard Intervention For Patients With Nonspecific Mechanical Neck Pain
Status: Enrolling
Updated:  3/12/2018
Loma Linda U
mi
from
Loma Linda, CA
Benefit of Adding Stretching to Standard Intervention For Patients With Nonspecific Mechanical Neck Pain
Benefit of Adding Stretching to Standard Intervention For Patients With Nonspecific Mechanical Neck Pain
Status: Enrolling
Updated: 3/12/2018
Loma Linda U
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Clinical Research Facility
mi
from
Atlanta, GA
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Clinical Research Facility
mi
from
Lawrence, KA
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Clinical Research Facility
mi
from
Lawrence, KA
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Clinical Research Facility
mi
from
Saint Paul, MN
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Clinical Research Facility
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Clinical Research Facility
mi
from
Kansas City, MO
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Clinical Research Facility
mi
from
Hackensack, NJ
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Clinical Research Facility
mi
from
Pittsburgh, PA
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Clinical Research Facility
mi
from
San Antonio, TX
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Clinical Research Facility
mi
from
Richmond, VA
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated:  3/12/2018
Research Site
mi
from
Adelaide,
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis
Status: Enrolling
Updated: 3/12/2018
Research Site
mi
from
Adelaide,
Click here to add this to my saved trials